eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 26
 
Share:
Share:
Original paper

Health after the pandemic: investigating risk factors for poorly controlled arterial hypertension and type 2 diabetes among elderly patients in primary care in Slovenia

Matic Mihevc
1, 2
,
Tina Virtič Potočnik
1, 3
,
Črt Zavrnik
1, 2
,
Marija Petek Šter
2
,
Zalika Klemenc-Ketiš
1, 3
,
Antonija Poplas Susič
1, 2

  1. Primary Healthcare Research and Development Institute, Health Centre Ljubljana, Ljubljana, Slovenia
  2. Department of Family Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
  3. Department of Family Medicine, Medical Faculty, University of Maribor, Maribor, Slovenia
Family Medicine & Primary Care Review 2024; 26(1): 67–73
Online publish date: 2024/03/15
Get citation
 
PlumX metrics:
 
1. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398(10304): 957–980, doi: 10.1016/S0140-6736(21)01330-1.
2. Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health 2019; 10(1): 107, doi: 10.2991/jegh.k.191028.001.
3. Khan HTA. Population ageing in a globalized world: Risks and dilemmas? J Eval Clin Pract 2019; 25(5): 754–760, doi: 10.1111/jep.13071.
4. Klemenc-Ketiš Z, Stojni N, Zavrnik , et al. Implementation of integrated primary care for patients with diabetes and hypertension: A case from Slovenia. Int J Integr Care 2021; 21(3): 15, doi: 10.5334/ijic.5637.
5. Mihevc M, Zavrnik , Mori Lukani M, et al. Telemonitoring of elderly with hypertension and type 2 diabetes at the primary care level: Protocol for a multicentric randomized controlled pilot study. Zdr Varst 2022; 61(4): 216–223, doi: 10.2478/sjph-2022-0029.
6. Hodgson S, Morgan-Harrisskitt J, Hounkpatin H, et al. Primary care service utilisation and outcomes in type 2 diabe-tes: a longitudinal cohort analysis. BMJ Open 2022; 12(1): e054654, doi: 10.1136/bmjopen-2021-054654.
7. Lu W, Pikhart H, Tamosiunas A, et al. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study. BMC Public Health 2022; 22(1): 883, doi: 10.1186/s12889-022-13260-3.
8. Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA 2020; 324(12): 1190–1200, doi: 10.1001/jama.2020.14545.
9. Fang M, Wang D, Coresh J, et al. Trends in diabetes treatment and control in U.S. adults, 1999–2018. N Engl J Med 2021; 384(23): 2219–2228, doi: 10.1056/NEJMsa2032271.
10. Petek Šter M, Barbi Žagar B. Treatment of patients with arterial hypertension in family medicine in Slovenia – As-sessment of the situation after the introduction of model practices. Zdrav Vestn 2021; 90(9–10): 478–487, doi: 10.6016/ZdravVestn.3069.
11. Petek D, Mlakar M. Quality of care for patients with diabetes mellitus type 2 in ‘model practices’ in Slovenia – first results. Zdr Varst 2016; 55(3): 179–184, doi: 10.1515/sjph-2016-0023.
12. Bitew ZW, Alemu A, Jember DA, et al. Prevalence of glycemic control and factors associated with poor glycemic con-trol: A systematic review and meta-analysis. Inquiry 2023; 60: 469580231155716, doi: 10.1177/00469580231155716.
13. Cheng LJ, Wang W, Lim ST, et al. Factors associated with glycaemic control in patients with diabetes mellitus: a systematic literature review. J Clin Nurs 2019; 28(9–10): 1433–1450, doi: 10.1111/jocn.
14. Fan Y, Long E, Cai L, et al. Machine learning approaches to predict risks of diabetic complications and poor glycemic control in nonadherent type 2 diabetes. Front Pharmacol 2021; 12: 665951, doi: 10.3389/fphar.2021.665951.
15. Visco V, Finelli R, Pascale AV, et al. Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control. J Hum Hypertens 2018; 32(7): 467–476, doi: 10.1038/s41371-018-0063-0.
16. Costa Filho FF, Timerman A, Saraiva JFK, et al. Independent predictors of effective blood pressure control in patients with hypertension on drug treatment in Brazil. J Clin Hypertens (Greenwich) 2018; 20(1): 125–132, doi: 10.1111/jch.13139.
17. Alotaibi A, Alotaibi A, Alsomail A, et al. Evaluation of knowledge and practices of hypertensive patients regarding home blood pressure monitoring. Fam Med Prim Care Rev 2023; 25(1): 7–13, doi: 10.5114/fmpcr.2023.125485.
18. Almaqhawi A, Turkistani J, Albahrani S, et al. Effect of telemedicine on glycated haemoglobin in people with type 2 diabetes in the MENA region: a systematic review and meta-analysis. Fam Med Prim Care Rev 2022; 24(4): 361–369, doi: 10.5114/fmpcr.2022.120861.
19. Eurostat. GDP change in the EU regions [Internet]. 2023 [cited 15.10.2023]. Available from URL: https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230220-1.
20. Alkandari A, Vaucher J, Marques-Vidal P. Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study. BMJ Open Diabetes Res Care 2023; 11(3): e003377, doi: 10.1136/bmjdrc-2023-003377.
21. Mancia Chairperson G, Kreutz Co-Chair R, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens 2023; 41(12): 1874–2071, doi: 10.1097/HJH.0000000000003480.
22. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J 2019; 41(2): 255–323, doi: 10.1093/eurheartj/ehz486.
23. Carey MP, Jorgensen RS, Weinstock RS, et al. Reliability and validity of the appraisal of diabetes scale. J Behav Med 1991; 14(1): 43–51, doi: 10.1007/BF00844767.
24. Mihevc M, Petek Šter M. Stigma and low sense of coherence as long-term predictors of depressive and anxiety symptoms in the population amid the COVID-19 pandemic. Psychiatr Danub 2023; 35(2): 250–259, doi: 10.24869/psyd.2023.250.
25. Dedefo MG, Gemechu DB, Fekadu G, et al. Blood pressure control among hypertensive diabetic patients on follow-up at chronic clinic of Nekemte Referral Hospital in West Ethiopia. Int J Hypertens 2020; 2020: 7526257, doi: 10.1155/2020/7526257.
26. Du HW, Li JY, He Y. Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis. J Geriatr Cardiol 2011; 8(1): 24–30, doi: 10.3724/SP.J.1263.2011.00024.
27. Venkatesh U, Grover A, Vignitha B, et al. Urban-rural disparities in blood pressure and lifestyle risk factors of hyper-tension among Indian individuals. J Family Med Prim Care 2022; 11(9): 5746–5756, doi: 10.4103/jfmpc.jfmpc_573_22.
28. Li J, Shi L, Li S, et al. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese adults from 1993 to 2011. Int J Equity Health 2017; 16(1): 50, doi: 10.1186/s12939-017-0545-7.
29. Pinter-Wollman N, Jeli A, Wells NM. The impact of the built environment on health behaviours and disease transmission in social systems. Philos Trans R Soc Lond B Biol Sci 2018; 373(1753): 20170245, doi: 10.1098/rstb.2017.0245.
30. Heindl B, Howard G, Clarkson S, et al. Urban-rural differences in hypertension prevalence, blood pressure control, and systolic blood pressure levels. J Hum Hypertens 2023; 37(12): 1112–1118, doi: 10.1038/s41371-023-00842-w.
31. Duarte FG, da Silva Moreira S, Almeida M, et al. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open 2019; 9(3): e023401, doi: 10.1136/bmjopen-2018-023401.
32. Choe S-A, Kim JY, Ro YS, et al. Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort. PLoS ONE 2018; 13(5): e0196719, doi: 10.1371/journal.pone.0196719.
33. Arnetz L, Rajamand Ekberg N, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and out-comes. Diabetes Metab Syndr Obes 2014; 7: 409–420, doi: 10.2147/DMSO.S51301.
34. Haghighatpanah M, Nejad ASM, Haghighatpanah M, et al. Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong Public Health Res Perspect 2018; 9(4): 167–174, doi: 10.24171/j.phrp.2018.9.4.05.
35. Vatcharavongvan P, Puttawanchai V. Polypharmacy, medication adherence and medication management at home in elderly patients with multiple non-communicable diseases in Thai primary care. Fam Med Prim Care Rev 2017; 19(4): 412–416, doi: 10.5114/fmpcr.2017.70818.
36. Vieira M, Rosendo I, Gomes P, et al. Health literacy and cardiovascular complications in people with type 2 Diabetes. Fam Med Prim Care Rev 2021; 23(4): 488–493, doi: 10.5114/fmpcr.2021.110367.
37. Prevolnik Rupel V, Divjak M, Turk E. Changes in the level of knowledge of diabetes among elderly with diabetes in Slovenia in the period 2011–2020. Prim Care Diabetes 2021; 15(5): 879–883, doi: 10.1016/j.pcd.2021.07.001.
38. Virti T, Mihevc M, Zavrnik , et al. Peer support as part of scaling-up integrated care in patients with type 2 diabetes and arterial hypertension at the primary healthcare level: a study protocol. Zdr Varst 2023; 62(2): 93–100, doi: 10.2478/sjph-2023-0013.
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.